U.S. Physical Therapy, Inc. (USPH)

NYQ – Real Time Price. Currency in USD

81.49

-0.18 (-0.23%)

Market open: Aug 12, 2026, 1:07 PM EDT

81.67

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

09.08.2026

U.S. Physical Therapy Q2 Earnings Call Highlights

U.S. Physical Therapy NYSE: USPH reported second-quarter 2026 revenue growth supported by higher patient volumes, improved reimbursement rates and the early rollout of hospital-affiliation agreements, while elevated employee healthcare claims and upfront staffing costs pressured physical therapy margins.

07.08.2026

U.S. Physical Therapy, Inc. (USPH) Q2 2026 Earnings Call Transcript

06.08.2026

U.S. Physical Therapy Continues To Heal

U.S. Physical Therapy, Inc. remains rated Hold as operational growth is offset by disappointing profitability and fair valuation. USPH exceeded revenue expectations in Q2 2026, but EPS fell short due to one-time events and rising costs. Clinic expansion, hospital affiliations, and industrial injury prevention services are driving top-line growth and future margin improvement.

06.08.2026

U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates

U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.75 per share, missing the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.81 per share a year ago.

06.08.2026

U.S. Physical Therapy (USPH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for U.S. Physical Therapy (USPH) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

05.08.2026

USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance

HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (“IIP”), today reported results for the three and six months ended June 30, 2026. Total net revenue of $214.1 million for the second quarter ended June 30, 2026 (“Q2 2026”), an 8.5% increase over the second quarter ended June 30, 2025 (“Q2 2025”). Net income attributable to USPH.

05.08.2026

Conestoga Micro Cap Composite Q2 2026 Leaders, Laggards, Buys And Sells

Revenue increased 19% year-over-year, reinforcing confidence that TWST's technology leadership and expanding product portfolio continue to drive market share gains. We continue to believe AORT's expanding aortic portfolio and product pipeline provide meaningful long-term growth opportunities. We remain encouraged by PLMR's disciplined underwriting approach, diversified specialty portfolio, and ability to historically deploy capital into attractive growth opportunities.

Videos

No Data

There is no data to display

Press releases

05.08.2026

U.S. Physical Therapy, Inc. (USPH)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

U.S. Physical Therapy, Inc. (USPH)

U.S. Physical Therapy Q2 Earnings Call Highlights

U.S. Physical Therapy, Inc. (USPH) Q2 2026 Earnings Call Transcript

U.S. Physical Therapy Continues To Heal

U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates

U.S. Physical Therapy (USPH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance

Conestoga Micro Cap Composite Q2 2026 Leaders, Laggards, Buys And Sells

Videos

No Data

Press releases

USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance

U.S. Physical Therapy Q2 Earnings Call Highlights

U.S. Physical Therapy, Inc. (USPH) Q2 2026 Earnings Call Transcript

U.S. Physical Therapy Continues To Heal

U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates

U.S. Physical Therapy (USPH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance

Conestoga Micro Cap Composite Q2 2026 Leaders, Laggards, Buys And Sells

Videos

No Data

Press releases

USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance

Search stocks

U.S. Physical Therapy, Inc. (USPH)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

U.S. Physical Therapy, Inc. (USPH)

U.S. Physical Therapy Q2 Earnings Call Highlights

U.S. Physical Therapy, Inc. (USPH) Q2 2026 Earnings Call Transcript

U.S. Physical Therapy Continues To Heal

U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates

U.S. Physical Therapy (USPH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance

Conestoga Micro Cap Composite Q2 2026 Leaders, Laggards, Buys And Sells

Videos

No Data

Press releases

USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance

U.S. Physical Therapy Q2 Earnings Call Highlights

U.S. Physical Therapy, Inc. (USPH) Q2 2026 Earnings Call Transcript

U.S. Physical Therapy Continues To Heal

U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates

U.S. Physical Therapy (USPH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance

Conestoga Micro Cap Composite Q2 2026 Leaders, Laggards, Buys And Sells

Videos

No Data

Press releases

USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance